Apr 16, 2018
69 Views

Compliance: Include Prescribing Practices!

Written by


Since the implementation of House Bill 1 in 2012, the restrictions on prescribing controlled substances have become more and more stringent, which is a response to the opioid epidemic sweeping Kentucky and the nation. The Cabinet for Health and Family Services, the Kentucky Board of Medical Licensure, the Kentucky Board of Nursing, and the Kentucky Board of Pharmacy are vigilant in policing prescribing practices and have tools through KASPER to closely monitor the prescribing practices of physicians and other practitioners. With the addition of new medications like Gabapentin to the controlled substances hit list, practitioners must be particularly careful to ensure that their prescribing is consistent with regulatory requirements, particularly when patients have been on this medication previously.   Physicians and practitioners must continually monitor compliance as even a minor violation can give rise to investigations, complaints and regulatory penalties.  Assessment of regulatory penalties, even when characterized as “Agreed Orders,” can have devastating consequences for physicians and practitioners’ practices and ability to maintain provider contracts, including Medicare and Medicaid. More >

Tags: Cabinet for Health and Family Services, Gabapentin, House Bill 1, KASPER, Kentucky Board of Medical Licensure, Kentucky Board of Nursing, Kentucky Board of Pharmacy, Medicaid, Medicare, National Practitioners Data Bank, Opioid Epidemic



Source link

Article Categories:
Uncategorized

Leave a Comment

Your email address will not be published. Required fields are marked *